Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Pfizer says CDC committee recommends PREVNAR 20 for routine use in adults » 16:21
10/20/21
10/20
16:21
10/20/21
16:21
PFE

Pfizer

$42.79 /

+0.7 (+1.66%)

Pfizer announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$42.79 /

+0.7 (+1.66%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
PFE Pfizer
$42.79 /

+0.7 (+1.66%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

PFE Pfizer
$42.79 /

+0.7 (+1.66%)

Yesterday
On The Fly
Wall Street in Fives - Must Read Lists for Tuesday » 16:46
10/19/21
10/19
16:46
10/19/21
16:46
FB

Facebook

$340.06 /

+4.62 (+1.38%)

, JNJ

Johnson & Johnson

$163.90 /

+3.77 (+2.35%)

, TRV

Travelers

$155.35 /

+2.52 (+1.65%)

, PG

Procter & Gamble

$140.69 /

-1.64 (-1.15%)

, AVIR

Atea Pharmaceuticals

$13.80 /

-26.75 (-65.97%)

, WMT

Walmart

$144.70 /

+3 (+2.12%)

, TGT

Target

$252.17 /

-1.52 (-0.60%)

, ALB

Albemarle

$235.80 /

-1.12 (-0.47%)

, AAPL

Apple

$148.81 /

+2.27 (+1.55%)

, Z

Zillow

$87.56 /

+1.565 (+1.82%)

, ZG

Zillow Group

$88.82 /

+3.34 (+3.91%)

, GME

GameStop

$186.95 /

+1.13 (+0.61%)

, GOOG

Alphabet

$2,876.49 /

+18.81 (+0.66%)

, GOOGL

Alphabet Class A

$2,864.52 /

+9.785 (+0.34%)

, CS

Credit Suisse

$10.61 /

+0.15 (+1.43%)

, MRNA

Moderna

$333.56 /

-1.41 (-0.42%)

, PFE

Pfizer

$42.09 /

+0.76 (+1.84%)

, BNTX

BioNTech

$262.96 /

+2 (+0.77%)

, AMZN

Amazon.com

$3,443.25 /

-3.4 (-0.10%)

, SBUX

Starbucks

$113.49 /

+0.11 (+0.10%)

, WATT

Energous

$2.16 /

+0.165 (+8.27%)

, APO

Apollo Global

$73.20 /

+4.92 (+7.21%)

, GRTX

Galera Therapeutics

$2.24 /

-5.17 (-69.77%)

, ULTA

Ulta Beauty

$363.23 /

-42.675 (-10.51%)

, TASK

TaskUs

$67.57 /

-5.065 (-6.97%)

, EVER

EverQuote

$15.00 /

-2.295 (-13.27%)

, PM

Philip Morris

$95.85 /

-1.54 (-1.58%)

, HAL

Halliburton

$26.10 /

+0.1 (+0.38%)

, KSU

Kansas City Southern

$297.47 /

+0.04 (+0.01%)

, ISRG

Intuitive Surgical

$336.63 /

+4.45 (+1.34%)

, STLD

Steel Dynamics

$63.51 /

+0.99 (+1.58%)

Get caught up quickly on…

ShowHide Related Items >><<
Z Zillow
$87.56 /

+1.565 (+1.82%)

WMT Walmart
$144.70 /

+3 (+2.12%)

WATT Energous
$2.16 /

+0.165 (+8.27%)

ULTA Ulta Beauty
$363.23 /

-42.675 (-10.51%)

TRV Travelers
$155.35 /

+2.52 (+1.65%)

TGT Target
$252.17 /

-1.52 (-0.60%)

STLD Steel Dynamics
$63.51 /

+0.99 (+1.58%)

SBUX Starbucks
$113.49 /

+0.11 (+0.10%)

PM Philip Morris
$95.85 /

-1.54 (-1.58%)

PG Procter & Gamble
$140.69 /

-1.64 (-1.15%)

PFE Pfizer
$42.09 /

+0.76 (+1.84%)

MRNA Moderna
$333.56 /

-1.41 (-0.42%)

KSU Kansas City Southern
$297.47 /

+0.04 (+0.01%)

JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

HAL Halliburton
$26.10 /

+0.1 (+0.38%)

GRTX Galera Therapeutics
$2.24 /

-5.17 (-69.77%)

GOOG Alphabet
$2,876.49 /

+18.81 (+0.66%)

GME GameStop
$186.95 /

+1.13 (+0.61%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

EVER EverQuote
$15.00 /

-2.295 (-13.27%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

BNTX BioNTech
$262.96 /

+2 (+0.77%)

AVIR Atea Pharmaceuticals
$13.80 /

-26.75 (-65.97%)

APO Apollo Global
$73.20 /

+4.92 (+7.21%)

AMZN Amazon.com
$3,443.25 /

-3.4 (-0.10%)

ALB Albemarle
$235.80 /

-1.12 (-0.47%)

AAPL Apple
$148.81 /

+2.27 (+1.55%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/18/21 Credit Suisse
Facebook algorithm, service outages grab investor attention, says Credit Suisse
10/15/21 Evercore ISI
Facebook added to 'Tactical Underperform List' at Evercore ISI
10/13/21 Tigress Financial
Facebook price target raised to $466 from $430 at Tigress Financial
JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

06:35 Today Baird
Intuitive Surgical price target raised to $370 from $350 at Baird
10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
TRV Travelers
$155.35 /

+2.52 (+1.65%)

08/16/21 Wolfe Research
Travelers initiated with an Outperform at Wolfe Research
07/22/21
Fly Intel: Top five analyst downgrades
07/22/21 BofA
BofA double downgrades Travelers to Underperform on 'Street low' 2022 forecast
07/22/21 BofA
Travelers downgraded to Underperform from Buy at BofA
PG Procter & Gamble
$140.69 /

-1.64 (-1.15%)

06:44 Today Deutsche Bank
Procter & Gamble price target lowered to $160 from $163 at Deutsche Bank
10/19/21 Stifel
Procter & Gamble Q1 results 'solid' amid added cost headwinds, says Stifel
10/05/21
Fly Intel: Top five analyst initiations
10/05/21 BofA
Procter & Gamble reinitiated with a Buy at BofA
AVIR Atea Pharmaceuticals
$13.80 /

-26.75 (-65.97%)

10/19/21 JPMorgan
Atea Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan
10/19/21 William Blair
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature'
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/18/21 JPMorgan
Atea Pharmaceuticals price target raised to $61 from $56 at JPMorgan
WMT Walmart
$144.70 /

+3 (+2.12%)

10/19/21
Fly Intel: Top five analyst upgrades
10/18/21 Goldman Sachs
Walmart upgraded to Conviction Buy from Buy at Goldman Sachs
10/06/21 Morgan Stanley
Affirm relationship with Target not new, says Morgan Stanley
09/29/21 Piper Sandler
Piper ups Impinj target to $75 after finding RFID in Walmart
TGT Target
$252.17 /

-1.52 (-0.60%)

10/19/21
Fly Intel: Top five analyst downgrades
10/18/21 Goldman Sachs
Target downgraded to Buy from Conviction Buy at Goldman Sachs
08/26/21 Tigress Financial
Target shares to hit $320 within 12 months, says Tigress Financial
ALB Albemarle
$235.80 /

-1.12 (-0.47%)

10/19/21 RBC Capital
Albemarle upgraded to Outperform from Sector Perform at RBC Capital
10/19/21 RBC Capital
Albemarle upgraded to Outperform from Sector Perform at RBC Capital
10/12/21 Mizuho
Albemarle initiated with a Neutral at Mizuho
AAPL Apple
$148.81 /

+2.27 (+1.55%)

10/19/21 JPMorgan
JPMorgan sees Q4 beat for Apple with 'deja-vu' guidance for Q1
10/19/21 DA Davidson
Apple price target raised to $175 from $167 at DA Davidson
10/19/21 Citi
Apple 'significantly better' at navigating supply disruptions, says Citi
10/19/21 Bernstein
Apple 14" Mac Pro high price may boost Mac ASPs, revenues, says Bernstein
Z Zillow
$87.56 /

+1.565 (+1.82%)

10/19/21 Jefferies
Zillow shares held back by macro concerns in near-term, says Jefferies
10/18/21 Piper Sandler
Zillow Group price target lowered to $117 from $174 at Piper Sandler
09/22/21 Piper Sandler
August home data positive for Zillow and Redfin, says Piper Sandler
08/09/21 Zelman
Zillow upgraded to Buy from Hold at Zelman
ZG Zillow Group
$88.82 /

+3.34 (+3.91%)

10/19/21 Wedbush
Wedbush downgrades Zillow Group to Neutral on Zillow Offers purchases pause
10/19/21 Wedbush
Zillow Group downgraded to Neutral from Outperform at Wedbush
GME GameStop
$186.95 /

+1.13 (+0.61%)

09/27/21 Ascendiant
Ascendiant keeps Sell rating on GameStop, cuts price target to $24
07/12/21 Ascendiant
GameStop price target raised to $25 from $10 at Ascendiant
06/28/21 Baird
Baird suspends GameStop rating pending business strategy clarity
06/10/21 Wedbush
GameStop price target raised to $50 from $39 at Wedbush
GOOG Alphabet
$2,876.49 /

+18.81 (+0.66%)

10/12/21 JPMorgan
JPMorgan says Alphabet 'clearly the most liked' mega-cap internet stock
10/07/21 Stephens
Comcast-branded Smart TV Launch in U.S. 'likely imminent,' says Stephens
10/07/21 Oppenheimer
AppLovin price target raised to $95 from $75 at Oppenheimer
GOOGL Alphabet Class A
$2,864.52 /

+9.785 (+0.34%)

10/18/21 Credit Suisse
Credit Suisse remains bullish on Alphabet ahead of quarterly results
CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

10/19/21 Kepler Cheuvreux
Credit Suisse upgraded to Buy from Hold at Kepler Cheuvreux
09/17/21 JPMorgan
Credit Suisse price target lowered to CHF 11.30 from CHF 11.60 at JPMorgan
08/12/21 Citi
Credit Suisse removed from EMEA Focus List at Citi
07/30/21 Barclays
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
MRNA Moderna
$333.56 /

-1.41 (-0.42%)

10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Piper Sandler
Moderna upgraded to Overweight from Neutral at Piper Sandler
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
PFE Pfizer
$42.09 /

+0.76 (+1.84%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$262.96 /

+2 (+0.77%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
AMZN Amazon.com
$3,443.25 /

-3.4 (-0.10%)

10/13/21 Baird
Amazon.com weakness would be a buying opportunity, says Baird
10/11/21 Loop Capital
Bed Bath & Beyond price target lowered to $14 from $18 at Loop Capital
SBUX Starbucks
$113.49 /

+0.11 (+0.10%)

10/11/21
Fly Intel: Top five analyst upgrades
10/11/21 Deutsche Bank
Starbucks upgraded to Buy after recent pullback at Deutsche Bank
10/11/21 BofA
Starbucks reinstated with a Buy at BofA
10/11/21 Deutsche Bank
Starbucks upgraded to Buy from Hold at Deutsche Bank
WATT Energous
$2.16 /

+0.165 (+8.27%)

09/09/21 Roth Capital
Energous management changes bring buying opportunity, says Roth Capital
07/30/21 Roth Capital
Energous price target lowered to $4 from $5 at Roth Capital
07/14/21 Roth Capital
Roth Capital 'encouraged' by Energous energy harvesting development kit
04/26/21 Roth Capital
Energous CEO leave to have limited impact, says Roth Capital
APO Apollo Global
$73.20 /

+4.92 (+7.21%)

06:05 Today Oppenheimer
Apollo Global downgraded to Perform from Outperform at Oppenheimer
10/14/21 BMO Capital
JPMorgan price target raised to $140 from $139 at BMO Capital
09/16/21 Morgan Stanley
Reported offer to keep floor under Tronox's share price, says Morgan Stanley
08/05/21 Oppenheimer
Apollo Global price target raised to $67 from $62 at Oppenheimer
GRTX Galera Therapeutics
$2.24 /

-5.17 (-69.77%)

06:06 Today H.C. Wainwright
Galera Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/19/21 BofA
Galera double downgraded to Underperform at BofA after ROMAN trial miss
10/19/21 BofA
Galera Therapeutics downgraded to Underperform from Buy at BofA
10/19/21 BTIG
Galera Therapeutics downgraded to Neutral from Buy at BTIG
ULTA Ulta Beauty
$363.23 /

-42.675 (-10.51%)

06:31 Today Baird
Ulta Beauty risk/reward attractive at current levels, says Baird
06:04 Today Piper Sandler
Ulta Beauty price target lowered to $433 from $470 at Piper Sandler
10/14/21 Deutsche Bank
Ulta Beauty price target raised to $483 from $478 at Deutsche Bank
10/08/21 Cleveland Research
Ulta Beauty upgraded to Buy from Neutral at Cleveland Research
TASK TaskUs
$67.57 /

-5.065 (-6.97%)

09/14/21
Fly Intel: Top five analyst downgrades
09/14/21 BofA
TaskUs downgraded to Neutral at BofA after 'huge run'
09/14/21 BofA
TaskUs downgraded to Neutral from Buy at BofA
08/17/21 JPMorgan
TaskUs price target raised to $52 from $50 at JPMorgan
EVER EverQuote
$15.00 /

-2.295 (-13.27%)

10/19/21 Needham
EverQuote price target lowered to $19 from $45 at Needham
08/03/21 Needham
EverQuote price target lowered to $45 from $65 at Needham
08/03/21 Oppenheimer
EverQuote price target lowered to $45 from $55 at Oppenheimer
08/03/21 JMP Securities
EverQuote price target lowered to $45 from $64 at JMP Securities
PM Philip Morris
$95.85 /

-1.54 (-1.58%)

09/30/21 Stifel
Stifel surprised and 'disappointed' by ITC banning IQOS importation
09/30/21 BofA
Altria, Philip Morris still well positioned despite IQOS 'setback,' says BofA
09/13/21 Stifel
Altria could trade down on news of Democrats' proposal, says Stifel
08/19/21 Deutsche Bank
Philip Morris price target raised to $120 from $114 at Deutsche Bank
HAL Halliburton
$26.10 /

+0.1 (+0.38%)

06:36 Today Barclays
Halliburton price target raised to $36 from $30 at Barclays
06:18 Today Citi
Halliburton price target raised to $30 from $28 at Citi
10/15/21 Northland
Northland would use potential weakness in oil services 'big 3' to add exposure
10/12/21 Coker Palmer
Halliburton upgraded to Outperform from Sector Perform at Coker Palmer
KSU Kansas City Southern
$297.47 /

+0.04 (+0.01%)

10/04/21 Barclays
Kansas City Southern price target lowered to $275 from $310 at Barclays
09/17/21 RBC Capital
Canadian National reinstated at Outperform from Sector Perform at RBC Capital
09/15/21
Fly Intel: Top five analyst downgrades
09/15/21 Wolfe Research
Kansas City Southern downgraded to Peer Perform from Outperform at Wolfe Research
ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

06:50 Today Deutsche Bank
Intuitive Surgical price target raised to $323 from $306 at Deutsche Bank
04:59 Today Piper Sandler
Intuitive Surgical price target raised to $330 from $323 at Piper Sandler
10/01/21 Citi
Intuitive Surgical downgraded to Neutral from Buy at Citi
STLD Steel Dynamics
$63.51 /

+0.99 (+1.58%)

10/18/21 Morgan Stanley
Morgan Stanley downgrades Steel Dynamics to Equal Weight on peak price worries
10/18/21 Morgan Stanley
Steel Dynamics downgraded to Equal Weight from Overweight at Morgan Stanley
09/15/21 Deutsche Bank
Steel Dynamics price target raised to $98 from $72 at Deutsche Bank
08/23/21 Seaport Global
Steel Dynamics initiated with a Buy at Seaport Global
ZG Zillow Group
$88.82 /

+3.34 (+3.91%)

Z Zillow
$87.56 /

+1.565 (+1.82%)

WMT Walmart
$144.70 /

+3 (+2.12%)

WATT Energous
$2.16 /

+0.165 (+8.27%)

ULTA Ulta Beauty
$363.23 /

-42.675 (-10.51%)

TRV Travelers
$155.35 /

+2.52 (+1.65%)

TGT Target
$252.17 /

-1.52 (-0.60%)

STLD Steel Dynamics
$63.51 /

+0.99 (+1.58%)

SBUX Starbucks
$113.49 /

+0.11 (+0.10%)

PM Philip Morris
$95.85 /

-1.54 (-1.58%)

PG Procter & Gamble
$140.69 /

-1.64 (-1.15%)

PFE Pfizer
$42.09 /

+0.76 (+1.84%)

MRNA Moderna
$333.56 /

-1.41 (-0.42%)

KSU Kansas City Southern
$297.47 /

+0.04 (+0.01%)

JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

HAL Halliburton
$26.10 /

+0.1 (+0.38%)

GRTX Galera Therapeutics
$2.24 /

-5.17 (-69.77%)

GOOG Alphabet
$2,876.49 /

+18.81 (+0.66%)

GME GameStop
$186.95 /

+1.13 (+0.61%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

EVER EverQuote
$15.00 /

-2.295 (-13.27%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

BNTX BioNTech
$262.96 /

+2 (+0.77%)

APO Apollo Global
$73.20 /

+4.92 (+7.21%)

AMZN Amazon.com
$3,443.25 /

-3.4 (-0.10%)

ALB Albemarle
$235.80 /

-1.12 (-0.47%)

AAPL Apple
$148.81 /

+2.27 (+1.55%)

  • 21
    Oct
  • 11
    Jun
  • 04
    Feb
  • 30
    Oct
Z Zillow
$87.56 /

+1.565 (+1.82%)

WMT Walmart
$144.70 /

+3 (+2.12%)

ULTA Ulta Beauty
$363.23 /

-42.675 (-10.51%)

TGT Target
$252.17 /

-1.52 (-0.60%)

STLD Steel Dynamics
$63.51 /

+0.99 (+1.58%)

SBUX Starbucks
$113.49 /

+0.11 (+0.10%)

PM Philip Morris
$95.85 /

-1.54 (-1.58%)

PG Procter & Gamble
$140.69 /

-1.64 (-1.15%)

MRNA Moderna
$333.56 /

-1.41 (-0.42%)

KSU Kansas City Southern
$297.47 /

+0.04 (+0.01%)

JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

HAL Halliburton
$26.10 /

+0.1 (+0.38%)

GOOG Alphabet
$2,876.49 /

+18.81 (+0.66%)

GME GameStop
$186.95 /

+1.13 (+0.61%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

BNTX BioNTech
$262.96 /

+2 (+0.77%)

AVIR Atea Pharmaceuticals
$13.80 /

-26.75 (-65.97%)

APO Apollo Global
$73.20 /

+4.92 (+7.21%)

AMZN Amazon.com
$3,443.25 /

-3.4 (-0.10%)

ALB Albemarle
$235.80 /

-1.12 (-0.47%)

AAPL Apple
$148.81 /

+2.27 (+1.55%)

WMT Walmart
$144.70 /

+3 (+2.12%)

WATT Energous
$2.16 /

+0.165 (+8.27%)

ULTA Ulta Beauty
$363.23 /

-42.675 (-10.51%)

TRV Travelers
$155.35 /

+2.52 (+1.65%)

TASK TaskUs
$67.57 /

-5.065 (-6.97%)

SBUX Starbucks
$113.49 /

+0.11 (+0.10%)

PM Philip Morris
$95.85 /

-1.54 (-1.58%)

PG Procter & Gamble
$140.69 /

-1.64 (-1.15%)

PFE Pfizer
$42.09 /

+0.76 (+1.84%)

MRNA Moderna
$333.56 /

-1.41 (-0.42%)

KSU Kansas City Southern
$297.47 /

+0.04 (+0.01%)

JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

HAL Halliburton
$26.10 /

+0.1 (+0.38%)

GOOG Alphabet
$2,876.49 /

+18.81 (+0.66%)

GME GameStop
$186.95 /

+1.13 (+0.61%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

BNTX BioNTech
$262.96 /

+2 (+0.77%)

APO Apollo Global
$73.20 /

+4.92 (+7.21%)

AMZN Amazon.com
$3,443.25 /

-3.4 (-0.10%)

ALB Albemarle
$235.80 /

-1.12 (-0.47%)

AAPL Apple
$148.81 /

+2.27 (+1.55%)

Z Zillow
$87.56 /

+1.565 (+1.82%)

WMT Walmart
$144.70 /

+3 (+2.12%)

WATT Energous
$2.16 /

+0.165 (+8.27%)

ULTA Ulta Beauty
$363.23 /

-42.675 (-10.51%)

TGT Target
$252.17 /

-1.52 (-0.60%)

TASK TaskUs
$67.57 /

-5.065 (-6.97%)

STLD Steel Dynamics
$63.51 /

+0.99 (+1.58%)

SBUX Starbucks
$113.49 /

+0.11 (+0.10%)

PM Philip Morris
$95.85 /

-1.54 (-1.58%)

PG Procter & Gamble
$140.69 /

-1.64 (-1.15%)

PFE Pfizer
$42.09 /

+0.76 (+1.84%)

MRNA Moderna
$333.56 /

-1.41 (-0.42%)

KSU Kansas City Southern
$297.47 /

+0.04 (+0.01%)

JNJ Johnson & Johnson
$163.90 /

+3.77 (+2.35%)

ISRG Intuitive Surgical
$336.63 /

+4.45 (+1.34%)

HAL Halliburton
$26.10 /

+0.1 (+0.38%)

GRTX Galera Therapeutics
$2.24 /

-5.17 (-69.77%)

GOOGL Alphabet Class A
$2,864.52 /

+9.785 (+0.34%)

GME GameStop
$186.95 /

+1.13 (+0.61%)

FB Facebook
$340.06 /

+4.62 (+1.38%)

CS Credit Suisse
$10.61 /

+0.15 (+1.43%)

APO Apollo Global
$73.20 /

+4.92 (+7.21%)

AMZN Amazon.com
$3,443.25 /

-3.4 (-0.10%)

ALB Albemarle
$235.80 /

-1.12 (-0.47%)

AAPL Apple
$148.81 /

+2.27 (+1.55%)

AAPL Apple
$148.81 /

+2.27 (+1.55%)

Hot Stocks
CDC says Pfizer vaccine 93% effective against hospitalization in ages 12-18 » 13:12
10/19/21
10/19
13:12
10/19/21
13:12
PFE

Pfizer

$42.13 /

+0.8 (+1.94%)

, BNTX

BioNTech

$265.11 /

+4.15 (+1.59%)

Among hospitalized U.S.…

Among hospitalized U.S. patients aged 12 to 18 years, vaccine effectiveness of two doses of the Pfizer-BioNTech vaccine against Covid-19 hospitalization during June through September was 93%, the Centers for Disease Control and Prevention announced. "This evaluation demonstrated that 2 doses of Pfizer-BioNTech vaccine were highly effective in preventing Covid-19 hospitalization among persons aged 12-18 years. Findings reinforce the importance of vaccination to protect U.S. youths against severe Covid-19," the agency concluded. In a test-negative, case-control study at 19 pediatric hospitals in 16 states during June 1 to September 30, the effectiveness of two doses of the Pfizer-BioNTech vaccine against Covid-19 hospitalization was assessed among children and adolescents aged 12-18 years. Among 464 hospitalized persons aged 12-18 years, the median age was 15 years, 72% had at least one underlying condition, including obesity, and 68% attended in-person school. Effectiveness of two doses of Pfizer-BioNTech vaccine against Covid hospitalization was 93% during the period when delta was the predominant variant. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$42.13 /

+0.8 (+1.94%)

BNTX BioNTech
$265.11 /

+4.15 (+1.59%)

PFE Pfizer
$42.13 /

+0.8 (+1.94%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$265.11 /

+4.15 (+1.59%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
PFE Pfizer
$42.13 /

+0.8 (+1.94%)

BNTX BioNTech
$265.11 /

+4.15 (+1.59%)

PFE Pfizer
$42.13 /

+0.8 (+1.94%)

BNTX BioNTech
$265.11 /

+4.15 (+1.59%)

PFE Pfizer
$42.13 /

+0.8 (+1.94%)

BNTX BioNTech
$265.11 /

+4.15 (+1.59%)

PFE Pfizer
$42.13 /

+0.8 (+1.94%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:26
10/19/21
10/19
12:26
10/19/21
12:26
JNJ

Johnson & Johnson

$164.85 /

+4.72 (+2.95%)

, TRV

Travelers

$157.00 /

+4.17 (+2.73%)

, PG

Procter & Gamble

$140.17 /

-2.16 (-1.52%)

, AVIR

Atea Pharmaceuticals

$15.05 /

-25.5 (-62.89%)

, STLD

Steel Dynamics

$63.39 /

+0.87 (+1.39%)

, GME

GameStop

$187.89 /

+2.07 (+1.11%)

, FB

Facebook

$340.21 /

+4.77 (+1.42%)

, HOOD

Robinhood

$41.00 /

+0.335 (+0.82%)

, GOOG

Alphabet

$2,870.96 /

+13.28 (+0.46%)

, GOOGL

Alphabet Class A

$2,857.27 /

+2.54 (+0.09%)

, MSFT

Microsoft

$307.78 /

+0.32 (+0.10%)

, CS

Credit Suisse

$10.59 /

+0.125 (+1.20%)

, MRNA

Moderna

$334.67 /

-0.3 (-0.09%)

, BNTX

BioNTech

$264.64 /

+3.68 (+1.41%)

, PFE

Pfizer

$42.16 /

+0.83 (+2.01%)

, WATT

Energous

$2.24 /

+0.245 (+12.28%)

, MRK

Merck

$79.02 /

+1.87 (+2.42%)

, GRTX

Galera Therapeutics

$2.36 /

-5.055 (-68.22%)

, DLO

dLocal

$55.30 /

-5.36 (-8.84%)

, TASK

TaskUs

$67.00 /

-5.64 (-7.76%)

, EVER

EverQuote

$14.74 /

-2.55 (-14.75%)

, PM

Philip Morris

$96.75 /

-0.64 (-0.66%)

, HAL

Halliburton

$26.23 /

+0.23 (+0.88%)

, KSU

Kansas City Southern

$297.13 /

-0.3 (-0.10%)

, MAN

ManpowerGroup

$105.98 /

-7.05 (-6.24%)

, WMT

Walmart

$144.01 /

+2.31 (+1.63%)

, TGT

Target

$252.66 /

-1.03 (-0.41%)

, ALB

Albemarle

$238.09 /

+1.17 (+0.49%)

, AAPL

Apple

$148.53 /

+1.99 (+1.36%)

, Z

Zillow

$85.99 /

-0.005 (-0.01%)

, ZG

Zillow Group

$86.24 /

+0.76 (+0.89%)

Get caught up quickly on…

ShowHide Related Items >><<
Z Zillow
$85.99 /

-0.005 (-0.01%)

WMT Walmart
$144.01 /

+2.31 (+1.63%)

WATT Energous
$2.24 /

+0.245 (+12.28%)

TRV Travelers
$157.00 /

+4.17 (+2.73%)

TGT Target
$252.66 /

-1.03 (-0.41%)

STLD Steel Dynamics
$63.39 /

+0.87 (+1.39%)

PM Philip Morris
$96.75 /

-0.64 (-0.66%)

PG Procter & Gamble
$140.17 /

-2.16 (-1.52%)

PFE Pfizer
$42.16 /

+0.83 (+2.01%)

MSFT Microsoft
$307.78 /

+0.32 (+0.10%)

MRNA Moderna
$334.67 /

-0.3 (-0.09%)

MRK Merck
$79.02 /

+1.87 (+2.42%)

MAN ManpowerGroup
$105.98 /

-7.05 (-6.24%)

KSU Kansas City Southern
$297.13 /

-0.3 (-0.10%)

JNJ Johnson & Johnson
$164.85 /

+4.72 (+2.95%)

HOOD Robinhood
$41.00 /

+0.335 (+0.82%)

HAL Halliburton
$26.23 /

+0.23 (+0.88%)

GRTX Galera Therapeutics
$2.36 /

-5.055 (-68.22%)

GOOG Alphabet
$2,870.96 /

+13.28 (+0.46%)

GME GameStop
$187.89 /

+2.07 (+1.11%)

FB Facebook
$340.21 /

+4.77 (+1.42%)

EVER EverQuote
$14.74 /

-2.55 (-14.75%)

DLO dLocal
$55.30 /

-5.36 (-8.84%)

CS Credit Suisse
$10.59 /

+0.125 (+1.20%)

BNTX BioNTech
$264.64 /

+3.68 (+1.41%)

AVIR Atea Pharmaceuticals
$15.05 /

-25.5 (-62.89%)

ALB Albemarle
$238.09 /

+1.17 (+0.49%)

AAPL Apple
$148.53 /

+1.99 (+1.36%)

JNJ Johnson & Johnson
$164.85 /

+4.72 (+2.95%)

10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
TRV Travelers
$157.00 /

+4.17 (+2.73%)

08/16/21 Wolfe Research
Travelers initiated with an Outperform at Wolfe Research
07/22/21
Fly Intel: Top five analyst downgrades
07/22/21 BofA
BofA double downgrades Travelers to Underperform on 'Street low' 2022 forecast
07/22/21 BofA
Travelers downgraded to Underperform from Buy at BofA
PG Procter & Gamble
$140.17 /

-2.16 (-1.52%)

10/05/21
Fly Intel: Top five analyst initiations
10/05/21 BofA
Procter & Gamble reinitiated with a Buy at BofA
10/05/21 BofA
Procter & Gamble reinitiated with a Buy at BofA
10/04/21 Deutsche Bank
Procter & Gamble price target raised to $163 from $160 at Deutsche Bank
AVIR Atea Pharmaceuticals
$15.05 /

-25.5 (-62.89%)

10/19/21 William Blair
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature'
10/19/21 Evercore ISI
Atea's Phase 2 design disappoints, but drug has not failed, says Evercore ISI
10/18/21 JPMorgan
Atea Pharmaceuticals price target raised to $61 from $56 at JPMorgan
10/05/21 Morgan Stanley
Atea downgraded to Equal Weight at Morgan Stanley following molnupiravir rally
STLD Steel Dynamics
$63.39 /

+0.87 (+1.39%)

10/18/21 Morgan Stanley
Morgan Stanley downgrades Steel Dynamics to Equal Weight on peak price worries
10/18/21 Morgan Stanley
Steel Dynamics downgraded to Equal Weight from Overweight at Morgan Stanley
09/15/21 Deutsche Bank
Steel Dynamics price target raised to $98 from $72 at Deutsche Bank
08/23/21 Seaport Global
Steel Dynamics initiated with a Buy at Seaport Global
GME GameStop
$187.89 /

+2.07 (+1.11%)

09/27/21 Ascendiant
Ascendiant keeps Sell rating on GameStop, cuts price target to $24
07/12/21 Ascendiant
GameStop price target raised to $25 from $10 at Ascendiant
06/28/21 Baird
Baird suspends GameStop rating pending business strategy clarity
06/10/21 Wedbush
GameStop price target raised to $50 from $39 at Wedbush
FB Facebook
$340.21 /

+4.77 (+1.42%)

10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/18/21 Credit Suisse
Facebook algorithm, service outages grab investor attention, says Credit Suisse
10/15/21 Evercore ISI
Facebook added to 'Tactical Underperform List' at Evercore ISI
10/13/21 Tigress Financial
Facebook price target raised to $466 from $430 at Tigress Financial
HOOD Robinhood
$41.00 /

+0.335 (+0.82%)

10/05/21 Mizuho
Most Robinhood users would pay small fee to stay on platform, says Mizuho
08/23/21
Fly Intel: Top five analyst initiations
08/23/21 Rosenblatt
Robinhood initiated with a Buy at Rosenblatt
08/23/21 JPMorgan
JPMorgan starts Robinhood at Underweight, says success priced into shares
GOOG Alphabet
$2,870.96 /

+13.28 (+0.46%)

10/12/21 JPMorgan
JPMorgan says Alphabet 'clearly the most liked' mega-cap internet stock
10/07/21 Stephens
Comcast-branded Smart TV Launch in U.S. 'likely imminent,' says Stephens
10/07/21 Oppenheimer
AppLovin price target raised to $95 from $75 at Oppenheimer
GOOGL Alphabet Class A
$2,857.27 /

+2.54 (+0.09%)

10/18/21 Credit Suisse
Credit Suisse remains bullish on Alphabet ahead of quarterly results
MSFT Microsoft
$307.78 /

+0.32 (+0.10%)

10/18/21 Morgan Stanley
Morgan Stanley says Cloud, Hybrid solutions should power 'strong' Microsoft Q1
10/06/21 Morgan Stanley
CIO survey shows Microsoft 'further solidifying leadership,' says Morgan Stanley
09/24/21 Oppenheimer
Opco downgrades Cloudflare amid competition from Amazon, Microsoft
09/24/21 Piper Sandler
Salesforce upgraded to Overweight from Neutral at Piper Sandler
CS Credit Suisse
$10.59 /

+0.125 (+1.20%)

10/19/21 Kepler Cheuvreux
Credit Suisse upgraded to Buy from Hold at Kepler Cheuvreux
09/17/21 JPMorgan
Credit Suisse price target lowered to CHF 11.30 from CHF 11.60 at JPMorgan
08/12/21 Citi
Credit Suisse removed from EMEA Focus List at Citi
07/30/21 Barclays
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
MRNA Moderna
$334.67 /

-0.3 (-0.09%)

10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Piper Sandler
Moderna upgraded to Overweight from Neutral at Piper Sandler
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
BNTX BioNTech
$264.64 /

+3.68 (+1.41%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
PFE Pfizer
$42.16 /

+0.83 (+2.01%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
WATT Energous
$2.24 /

+0.245 (+12.28%)

09/09/21 Roth Capital
Energous management changes bring buying opportunity, says Roth Capital
07/30/21 Roth Capital
Energous price target lowered to $4 from $5 at Roth Capital
07/14/21 Roth Capital
Roth Capital 'encouraged' by Energous energy harvesting development kit
04/26/21 Roth Capital
Energous CEO leave to have limited impact, says Roth Capital
MRK Merck
$79.02 /

+1.87 (+2.42%)

10/13/21 Citi
FDA likely to approve Merck EUA for molnupiravir, says Citi
GRTX Galera Therapeutics
$2.36 /

-5.055 (-68.22%)

10/19/21 BTIG
Galera Therapeutics downgraded to Neutral from Buy at BTIG
10/19/21 Roth Capital
Roth Capital bullish on Monopar Therapeutics after competitor trial fails
04/26/21 Credit Suisse
Galera Therapeutics assumed with an Outperform at Credit Suisse
12/16/20 Credit Suisse
Galera Therapeutics upgraded to Outperform from Neutral at Credit Suisse
DLO dLocal
$55.30 /

-5.36 (-8.84%)

08/19/21 HSBC
dLocal price target raised to $55 from $52 at HSBC
08/06/21 New Street
dLocal initiated with a Neutral at New Street
07/09/21 HSBC
dLocal initiated with a Hold at HSBC
06/28/21
Fly Intel: Top five analyst initiations
TASK TaskUs
$67.00 /

-5.64 (-7.76%)

09/14/21
Fly Intel: Top five analyst downgrades
09/14/21 BofA
TaskUs downgraded to Neutral at BofA after 'huge run'
09/14/21 BofA
TaskUs downgraded to Neutral from Buy at BofA
08/17/21 JPMorgan
TaskUs price target raised to $52 from $50 at JPMorgan
EVER EverQuote
$14.74 /

-2.55 (-14.75%)

10/19/21 Needham
EverQuote price target lowered to $19 from $45 at Needham
08/03/21 Needham
EverQuote price target lowered to $45 from $65 at Needham
08/03/21 Oppenheimer
EverQuote price target lowered to $45 from $55 at Oppenheimer
08/03/21 JMP Securities
EverQuote price target lowered to $45 from $64 at JMP Securities
PM Philip Morris
$96.75 /

-0.64 (-0.66%)

09/30/21 Stifel
Stifel surprised and 'disappointed' by ITC banning IQOS importation
09/30/21 BofA
Altria, Philip Morris still well positioned despite IQOS 'setback,' says BofA
09/13/21 Stifel
Altria could trade down on news of Democrats' proposal, says Stifel
08/19/21 Deutsche Bank
Philip Morris price target raised to $120 from $114 at Deutsche Bank
HAL Halliburton
$26.23 /

+0.23 (+0.88%)

10/15/21 Northland
Northland would use potential weakness in oil services 'big 3' to add exposure
10/12/21 Coker Palmer
Halliburton upgraded to Outperform from Sector Perform at Coker Palmer
09/13/21 Citi
Citi positive on oilfield services, upgrades Liberty to Buy, RPC to Neutral
09/08/21 RBC Capital
Halliburton assumed with an Outperform at RBC Capital
KSU Kansas City Southern
$297.13 /

-0.3 (-0.10%)

10/04/21 Barclays
Kansas City Southern price target lowered to $275 from $310 at Barclays
09/17/21 RBC Capital
Canadian National reinstated at Outperform from Sector Perform at RBC Capital
09/15/21
Fly Intel: Top five analyst downgrades
09/15/21 Wolfe Research
Kansas City Southern downgraded to Peer Perform from Outperform at Wolfe Research
MAN ManpowerGroup
$105.98 /

-7.05 (-6.24%)

09/17/21 Barclays
ManpowerGroup downgraded to Underweight from Overweight at Barclays
08/25/21 Truist
ManpowerGroup price target raised to $140 from $130 at Truist
07/21/21 Credit Suisse
ManpowerGroup price target raised to $115 from $110 at Credit Suisse
04/26/21 Barclays
ManpowerGroup price target raised to $140 from $120 at Barclays
WMT Walmart
$144.01 /

+2.31 (+1.63%)

10/19/21
Fly Intel: Top five analyst upgrades
10/18/21 Goldman Sachs
Walmart upgraded to Conviction Buy from Buy at Goldman Sachs
10/06/21 Morgan Stanley
Affirm relationship with Target not new, says Morgan Stanley
09/29/21 Piper Sandler
Piper ups Impinj target to $75 after finding RFID in Walmart
TGT Target
$252.66 /

-1.03 (-0.41%)

10/19/21
Fly Intel: Top five analyst downgrades
10/18/21 Goldman Sachs
Target downgraded to Buy from Conviction Buy at Goldman Sachs
08/26/21 Tigress Financial
Target shares to hit $320 within 12 months, says Tigress Financial
ALB Albemarle
$238.09 /

+1.17 (+0.49%)

10/19/21 RBC Capital
Albemarle upgraded to Outperform from Sector Perform at RBC Capital
10/19/21 RBC Capital
Albemarle upgraded to Outperform from Sector Perform at RBC Capital
10/12/21 Mizuho
Albemarle initiated with a Neutral at Mizuho
AAPL Apple
$148.53 /

+1.99 (+1.36%)

10/19/21 JPMorgan
JPMorgan sees Q4 beat for Apple with 'deja-vu' guidance for Q1
10/19/21 DA Davidson
Apple price target raised to $175 from $167 at DA Davidson
10/19/21 Citi
Apple 'significantly better' at navigating supply disruptions, says Citi
10/19/21 Bernstein
Apple 14" Mac Pro high price may boost Mac ASPs, revenues, says Bernstein
Z Zillow
$85.99 /

-0.005 (-0.01%)

10/19/21 Jefferies
Zillow shares held back by macro concerns in near-term, says Jefferies
10/18/21 Piper Sandler
Zillow Group price target lowered to $117 from $174 at Piper Sandler
09/22/21 Piper Sandler
August home data positive for Zillow and Redfin, says Piper Sandler
08/09/21 Zelman
Zillow upgraded to Buy from Hold at Zelman
ZG Zillow Group
$86.24 /

+0.76 (+0.89%)

10/19/21 Wedbush
Wedbush downgrades Zillow Group to Neutral on Zillow Offers purchases pause
10/19/21 Wedbush
Zillow Group downgraded to Neutral from Outperform at Wedbush
ZG Zillow Group
$86.24 /

+0.76 (+0.89%)

Z Zillow
$85.99 /

-0.005 (-0.01%)

WMT Walmart
$144.01 /

+2.31 (+1.63%)

WATT Energous
$2.24 /

+0.245 (+12.28%)

TRV Travelers
$157.00 /

+4.17 (+2.73%)

TGT Target
$252.66 /

-1.03 (-0.41%)

STLD Steel Dynamics
$63.39 /

+0.87 (+1.39%)

PM Philip Morris
$96.75 /

-0.64 (-0.66%)

PG Procter & Gamble
$140.17 /

-2.16 (-1.52%)

PFE Pfizer
$42.16 /

+0.83 (+2.01%)

MSFT Microsoft
$307.78 /

+0.32 (+0.10%)

MRNA Moderna
$334.67 /

-0.3 (-0.09%)

MRK Merck
$79.02 /

+1.87 (+2.42%)

MAN ManpowerGroup
$105.98 /

-7.05 (-6.24%)

KSU Kansas City Southern
$297.13 /

-0.3 (-0.10%)

JNJ Johnson & Johnson
$164.85 /

+4.72 (+2.95%)

HOOD Robinhood
$41.00 /

+0.335 (+0.82%)

HAL Halliburton
$26.23 /

+0.23 (+0.88%)

GRTX Galera Therapeutics
$2.36 /

-5.055 (-68.22%)

GOOG Alphabet
$2,870.96 /

+13.28 (+0.46%)

GME GameStop
$187.89 /

+2.07 (+1.11%)

FB Facebook
$340.21 /

+4.77 (+1.42%)

EVER EverQuote
$14.74 /

-2.55 (-14.75%)

DLO dLocal
$55.30 /

-5.36 (-8.84%)

CS Credit Suisse
$10.59 /

+0.125 (+1.20%)

BNTX BioNTech
$264.64 /

+3.68 (+1.41%)

ALB Albemarle
$238.09 /

+1.17 (+0.49%)

AAPL Apple
$148.53 /

+1.99 (+1.36%)

  • 21
    Oct
  • 21
    Oct
  • 29
    Jul
  • 11
    Jun
  • 03
    Jun
  • 04
    Feb
  • 30
    Oct
Z Zillow
$85.99 /

-0.005 (-0.01%)

WMT Walmart
$144.01 /

+2.31 (+1.63%)

TGT Target
$252.66 /

-1.03 (-0.41%)

STLD Steel Dynamics
$63.39 /

+0.87 (+1.39%)

PM Philip Morris
$96.75 /

-0.64 (-0.66%)

PG Procter & Gamble
$140.17 /

-2.16 (-1.52%)

MSFT Microsoft
$307.78 /

+0.32 (+0.10%)

MRNA Moderna
$334.67 /

-0.3 (-0.09%)

MRK Merck
$79.02 /

+1.87 (+2.42%)

KSU Kansas City Southern
$297.13 /

-0.3 (-0.10%)

JNJ Johnson & Johnson
$164.85 /

+4.72 (+2.95%)

HOOD Robinhood
$41.00 /

+0.335 (+0.82%)

HAL Halliburton
$26.23 /

+0.23 (+0.88%)

GOOG Alphabet
$2,870.96 /

+13.28 (+0.46%)

GME GameStop
$187.89 /

+2.07 (+1.11%)

FB Facebook
$340.21 /

+4.77 (+1.42%)

DLO dLocal
$55.30 /

-5.36 (-8.84%)

CS Credit Suisse
$10.59 /

+0.125 (+1.20%)

BNTX BioNTech
$264.64 /

+3.68 (+1.41%)

AVIR Atea Pharmaceuticals
$15.05 /

-25.5 (-62.89%)

ALB Albemarle
$238.09 /

+1.17 (+0.49%)

AAPL Apple
$148.53 /

+1.99 (+1.36%)

Z Zillow
$85.99 /

-0.005 (-0.01%)

WMT Walmart
$144.01 /

+2.31 (+1.63%)

WATT Energous
$2.24 /

+0.245 (+12.28%)

TRV Travelers
$157.00 /

+4.17 (+2.73%)

TGT Target
$252.66 /

-1.03 (-0.41%)

TASK TaskUs
$67.00 /

-5.64 (-7.76%)

STLD Steel Dynamics
$63.39 /

+0.87 (+1.39%)

PM Philip Morris
$96.75 /

-0.64 (-0.66%)

PG Procter & Gamble
$140.17 /

-2.16 (-1.52%)

PFE Pfizer
$42.16 /

+0.83 (+2.01%)

MSFT Microsoft
$307.78 /

+0.32 (+0.10%)

MRNA Moderna
$334.67 /

-0.3 (-0.09%)

MRK Merck
$79.02 /

+1.87 (+2.42%)

KSU Kansas City Southern
$297.13 /

-0.3 (-0.10%)

JNJ Johnson & Johnson
$164.85 /

+4.72 (+2.95%)

HOOD Robinhood
$41.00 /

+0.335 (+0.82%)

HAL Halliburton
$26.23 /

+0.23 (+0.88%)

GOOG Alphabet
$2,870.96 /

+13.28 (+0.46%)

GME GameStop
$187.89 /

+2.07 (+1.11%)

FB Facebook
$340.21 /

+4.77 (+1.42%)

DLO dLocal
$55.30 /

-5.36 (-8.84%)

CS Credit Suisse
$10.59 /

+0.125 (+1.20%)

BNTX BioNTech
$264.64 /

+3.68 (+1.41%)

AVIR Atea Pharmaceuticals
$15.05 /

-25.5 (-62.89%)

ALB Albemarle
$238.09 /

+1.17 (+0.49%)

AAPL Apple
$148.53 /

+1.99 (+1.36%)

Z Zillow
$85.99 /

-0.005 (-0.01%)

WMT Walmart
$144.01 /

+2.31 (+1.63%)

WATT Energous
$2.24 /

+0.245 (+12.28%)

TGT Target
$252.66 /

-1.03 (-0.41%)

TASK TaskUs
$67.00 /

-5.64 (-7.76%)

STLD Steel Dynamics
$63.39 /

+0.87 (+1.39%)

PM Philip Morris
$96.75 /

-0.64 (-0.66%)

PG Procter & Gamble
$140.17 /

-2.16 (-1.52%)

PFE Pfizer
$42.16 /

+0.83 (+2.01%)

MSFT Microsoft
$307.78 /

+0.32 (+0.10%)

MRNA Moderna
$334.67 /

-0.3 (-0.09%)

MRK Merck
$79.02 /

+1.87 (+2.42%)

KSU Kansas City Southern
$297.13 /

-0.3 (-0.10%)

JNJ Johnson & Johnson
$164.85 /

+4.72 (+2.95%)

HOOD Robinhood
$41.00 /

+0.335 (+0.82%)

HAL Halliburton
$26.23 /

+0.23 (+0.88%)

GRTX Galera Therapeutics
$2.36 /

-5.055 (-68.22%)

GOOGL Alphabet Class A
$2,857.27 /

+2.54 (+0.09%)

GME GameStop
$187.89 /

+2.07 (+1.11%)

FB Facebook
$340.21 /

+4.77 (+1.42%)

DLO dLocal
$55.30 /

-5.36 (-8.84%)

CS Credit Suisse
$10.59 /

+0.125 (+1.20%)

ALB Albemarle
$238.09 /

+1.17 (+0.49%)

AAPL Apple
$148.53 /

+1.99 (+1.36%)

AAPL Apple
$148.53 /

+1.99 (+1.36%)

Hot Stocks
Candel Therapeutics appoints Mace Rothenberg as senior advisor to CEO » 08:09
10/19/21
10/19
08:09
10/19/21
08:09
CADL

Candel Therapeutics

$9.81 /

+0.02 (+0.20%)

, PFE

Pfizer

$41.33 /

-0.16 (-0.39%)

Candel Therapeutics, Inc.…

Candel Therapeutics, Inc. (CADL) announced it has appointed Mace Rothenberg, MD, as a senior advisor to its President and CEO, Paul Peter Tak, MD, PhD, FMedSci. Prior to joining Candel, Dr. Rothenberg served as Chief Medical Officer of Pfizer (PFE). During that time, the company initiated, completed, and obtained emergency use authorization for its COVID-19 vaccine.

ShowHide Related Items >><<
PFE Pfizer
$41.33 /

-0.16 (-0.39%)

CADL Candel Therapeutics
$9.81 /

+0.02 (+0.20%)

CADL Candel Therapeutics
$9.81 /

+0.02 (+0.20%)

08/23/21 UBS
Candel Therapeutics initiated with a Buy at UBS
08/23/21 Jefferies
Candel Therapeutics initiated with a Buy at Jefferies
08/23/21 Credit Suisse
Candel Therapeutics initiated with an Outperform at Credit Suisse
PFE Pfizer
$41.33 /

-0.16 (-0.39%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
PFE Pfizer
$41.33 /

-0.16 (-0.39%)

CADL Candel Therapeutics
$9.81 /

+0.02 (+0.20%)

  • 27
    Jul
PFE Pfizer
$41.33 /

-0.16 (-0.39%)

PFE Pfizer
$41.33 /

-0.16 (-0.39%)

CADL Candel Therapeutics
$9.81 /

+0.02 (+0.20%)

PFE Pfizer
$41.33 /

-0.16 (-0.39%)

Hot Stocks
Myovant Sciences and Pfizer to present data from relugolix studies » 07:02
10/19/21
10/19
07:02
10/19/21
07:02
MYOV

Myovant Sciences

$20.30 /

-0.45 (-2.17%)

, PFE

Pfizer

$41.33 /

-0.16 (-0.39%)

Myovant Sciences (MYOV)…

Myovant Sciences (MYOV) and Pfizer (PFE) announced the presentation of new data from clinical studies of its once-daily relugolix combination therapy in premenopausal women with uterine fibroids and in women with endometriosis pain. The data are being presented in oral sessions during the American Society for Reproductive Medicine, or ASRM, 2021 Congress.

ShowHide Related Items >><<
PFE Pfizer
$41.33 /

-0.16 (-0.39%)

MYOV Myovant Sciences
$20.30 /

-0.45 (-2.17%)

MYOV Myovant Sciences
$20.30 /

-0.45 (-2.17%)

09/09/21 SVB Leerink
SVB Leerink starts Myovant at Market Perform
09/09/21 SVB Leerink
Myovant Sciences initiated with a Market Perform at SVB Leerink
08/19/21 Goldman Sachs
Myovant Sciences assumed with a Neutral at Goldman Sachs
05/13/21 Citi
Myovant Sciences price target lowered to $24 from $30 at Citi
PFE Pfizer
$41.33 /

-0.16 (-0.39%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
PFE Pfizer
$41.33 /

-0.16 (-0.39%)

MYOV Myovant Sciences
$20.30 /

-0.45 (-2.17%)

PFE Pfizer
$41.33 /

-0.16 (-0.39%)

PFE Pfizer
$41.33 /

-0.16 (-0.39%)

MYOV Myovant Sciences
$20.30 /

-0.45 (-2.17%)

PFE Pfizer
$41.33 /

-0.16 (-0.39%)

Monday
Periodicals
FDA may act this week on mix-and-match for COVID vaccines, NYT says » 18:05
10/18/21
10/18
18:05
10/18/21
18:05
MRNA

Moderna

$334.69 /

+10.66 (+3.29%)

, PFE

Pfizer

$41.33 /

-0.16 (-0.39%)

, BNTX

BioNTech

$261.00 /

+13.24 (+5.34%)

The FDA intends to allow…

The FDA intends to allow Americans to get a different COVID-19 vaccine as a booster from the one that originally had, The New York Times' Sharon LaFraniere and Noah Weiland report. This could reduce the appeal of Johnson & Johnson (JNJ) vaccine and provide flexibility to doctors and other vaccinators, the report states, though the government would not recommend one shot over another, the report states, further indicating that the FDA is expected to authorize boosters of the Moderna (MRNA) and JNJ vaccines by Wednesday evening and allow the mix-and-match approach by then. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$41.33 /

-0.16 (-0.39%)

MRNA Moderna
$334.69 /

+10.66 (+3.29%)

BNTX BioNTech
$261.00 /

+13.24 (+5.34%)

MRNA Moderna
$334.69 /

+10.66 (+3.29%)

10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Piper Sandler
Moderna upgraded to Overweight from Neutral at Piper Sandler
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
PFE Pfizer
$41.33 /

-0.16 (-0.39%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$261.00 /

+13.24 (+5.34%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
PFE Pfizer
$41.33 /

-0.16 (-0.39%)

MRNA Moderna
$334.69 /

+10.66 (+3.29%)

BNTX BioNTech
$261.00 /

+13.24 (+5.34%)

PFE Pfizer
$41.33 /

-0.16 (-0.39%)

MRNA Moderna
$334.69 /

+10.66 (+3.29%)

BNTX BioNTech
$261.00 /

+13.24 (+5.34%)

PFE Pfizer
$41.33 /

-0.16 (-0.39%)

MRNA Moderna
$334.69 /

+10.66 (+3.29%)

BNTX BioNTech
$261.00 /

+13.24 (+5.34%)

PFE Pfizer
$41.33 /

-0.16 (-0.39%)

MRNA Moderna
$334.69 /

+10.66 (+3.29%)

Hot Stocks
EMA starts evaluating Pfizer/BioNTech COVID vaccine use in kids aged 5 to 11 » 10:38
10/18/21
10/18
10:38
10/18/21
10:38
PFE

Pfizer

$41.39 /

-0.1 (-0.24%)

, BNTX

BioNTech

$251.69 /

+3.93 (+1.59%)

The EMA announced that it…

The EMA announced that it has started evaluating an application to extend the use of BioNTech (BNTX) and Pfizer's (PFE) COVID-19 vaccine, Comirnaty, to children aged 5 to 11. The EMA said its human medicines committee, or CHMP, will review the data on the vaccine, including results from an ongoing clinical study involving children aged 5 to 11, in order to decide whether to recommend extending its use. The CHMP's opinion will then be forwarded to the European Commission, which will issue a final decision. "EMA will communicate on the outcome of its evaluation, which is expected in a couple of months unless supplementary information is needed," the group stated. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$41.39 /

-0.1 (-0.24%)

BNTX BioNTech
$251.69 /

+3.93 (+1.59%)

PFE Pfizer
$41.39 /

-0.1 (-0.24%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$251.69 /

+3.93 (+1.59%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
PFE Pfizer
$41.39 /

-0.1 (-0.24%)

BNTX BioNTech
$251.69 /

+3.93 (+1.59%)

PFE Pfizer
$41.39 /

-0.1 (-0.24%)

BNTX BioNTech
$251.69 /

+3.93 (+1.59%)

PFE Pfizer
$41.39 /

-0.1 (-0.24%)

BNTX BioNTech
$251.69 /

+3.93 (+1.59%)

PFE Pfizer
$41.39 /

-0.1 (-0.24%)

Hot Stocks
EMA approves new manufacturing sites, new formulation for Pfizer/BioNTech shot » 10:35
10/18/21
10/18
10:35
10/18/21
10:35
PFE

Pfizer

$41.40 /

-0.09 (-0.22%)

, BNTX

BioNTech

$252.00 /

+4.24 (+1.71%)

The EMA announced that…

The EMA announced that its human medicines committee, or CHMP, has approved two additional manufacturing sites for the production of Comirnaty, the COVID-19 vaccine developed by BioNTech (BNTX) and Pfizer (PFE). "These sites will produce up to 85 million additional doses to supply the EU in 2021. These recommendations do not require a European Commission decision and the sites can become operational immediately," the EMA stated. In addition, the CHMP has approved a ready-to-use formulation of Comirnaty. "This formulation does not require dilution prior to administration, will be available in a 10-vial, 60 dose pack size and can be stored at 2-8 degrees C for up to 10 weeks," the EMA stated. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$41.40 /

-0.09 (-0.22%)

BNTX BioNTech
$252.00 /

+4.24 (+1.71%)

PFE Pfizer
$41.40 /

-0.09 (-0.22%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$252.00 /

+4.24 (+1.71%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
PFE Pfizer
$41.40 /

-0.09 (-0.22%)

BNTX BioNTech
$252.00 /

+4.24 (+1.71%)

PFE Pfizer
$41.40 /

-0.09 (-0.22%)

BNTX BioNTech
$252.00 /

+4.24 (+1.71%)

PFE Pfizer
$41.40 /

-0.09 (-0.22%)

BNTX BioNTech
$252.00 /

+4.24 (+1.71%)

PFE Pfizer
$41.40 /

-0.09 (-0.22%)

Periodicals
Pfizer, Moderna forecasted to make $93.2B in combined sales in 2022, FT reports » 06:26
10/18/21
10/18
06:26
10/18/21
06:26
PFE

Pfizer

$41.49 /

-0.18 (-0.43%)

, BNTX

BioNTech

$247.70 /

-2.44 (-0.98%)

, MRNA

Moderna

$324.02 /

-7.73 (-2.33%)

, AZN

AstraZeneca

$60.22 /

+0.52 (+0.87%)

, JNJ

Johnson & Johnson

$161.35 /

+1.27 (+0.79%)

BioNTech (BNTX) / Pfizer…

BioNTech (BNTX) / Pfizer (PFE) and Moderna (MRNA) is projected to generate $93.2B in combined sales in 2022, nearly double the amount of revenue compared to 2021, Jamie Smith of The Financial Times reports, citing projections by Airfinity. Airfinity also suggested the two vaccines will control three-quarters of the non-Chinese COVID-19 vaccine market next year. AstraZeneca (AZN), Johnson & Johnson (JNJ), Russia's Sputnik V, and any other new entrants make up the remainder of the market, which is forecasted to value $124B next year, which is also double the revenue of this year, The Financial Times reports, citing the forecasts by Airfinity. "We expect continued high sales levels in 2022 as countries seek continued protection and low- and middle-income countries seek similar vaccination levels to what many high-income countries have achieved," Rasmus Bech Hansen, Airfinity's CEO, said, according to The Financial Times. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$41.49 /

-0.18 (-0.43%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

BNTX BioNTech
$247.70 /

-2.44 (-0.98%)

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

PFE Pfizer
$41.49 /

-0.18 (-0.43%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$247.70 /

-2.44 (-0.98%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
MRNA Moderna
$324.02 /

-7.73 (-2.33%)

10/15/21
Fly Intel: Top five analyst upgrades
10/15/21 Piper Sandler
Moderna upgraded to Overweight from Neutral at Piper Sandler
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

10/11/21 Deutsche Bank
AstraZeneca price target raised to 10,500 GBp from 10,200 GBp at Deutsche Bank
09/29/21 Stifel
Zentalis initiated with a Buy at Stifel
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
09/28/21 Oppenheimer
Zentalis initiated with an Outperform at Oppenheimer
JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
10/04/21 Piper Sandler
Xencor price target raised to $75 from $63 at Piper Sandler
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
PFE Pfizer
$41.49 /

-0.18 (-0.43%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

BNTX BioNTech
$247.70 /

-2.44 (-0.98%)

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

PFE Pfizer
$41.49 /

-0.18 (-0.43%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

BNTX BioNTech
$247.70 /

-2.44 (-0.98%)

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

PFE Pfizer
$41.49 /

-0.18 (-0.43%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

BNTX BioNTech
$247.70 /

-2.44 (-0.98%)

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

PFE Pfizer
$41.49 /

-0.18 (-0.43%)

MRNA Moderna
$324.02 /

-7.73 (-2.33%)

JNJ Johnson & Johnson
$161.35 /

+1.27 (+0.79%)

AZN AstraZeneca
$60.22 /

+0.52 (+0.87%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.